Radiotherapy uses high-energy rays to treat diseases, this therapy can be given both internally and externally. Basically radiotherapy works by destroying cancer cells in the area that’s been affected; at the time of treatment usually normal cells can also be damaged by radiotherapy. Normal cells can recover after radiotherapy then cancer cells, as these cancer cells cannot repair themselves after radiotherapy. Key drivers for the global radiotherapy device market are rising incidence and prevalence of cancer, rising technological advancements such as stereotactic body radiation therapy, advancements in proton therapy, rising adoption of radiotherapy devices and procedures, growing geriatric population as persons over 65 years reported for 60% of newly diagnosed malignancies and 70% of all cancer deathsand increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy. However, the major restraining factors of the global radiotherapy device market are lack of adequate healthcare infrastructure and lack of trained personnel. Apart from this, the major challenges present in the market are difficulties in visualizing tumors during radiation procedures and affordability and accessibility of treatment. However, to overcome these market challenges, key opportunities for the global radiotherapy device market are emerging markets and rising investments to meet the increased demand for cancer treatment.
People having going through the radiotherapy treatment are treated with specialist doctors in radiation known as oncologists. This kind of treatment related mainly cancer and malignant tumors are diagnosed and treated in big super specialty hospitals. The treatment is not cheap neither easy as it takes toll on the mental and physical aspects of a patient. This treatment came into existence due to the scientific discipline of physics and biology. It is rarely used for treatments relating to thyroids and sometimes noncancerous tumors. Recent advances in radiation therapy are making it possible for oncologists to move from 2-D imaging to 4-D and to provide more targeted treatment. This will allow for escalation in the radiation dose, thus potentially treating the cancer more effectively, reducing the amount of time that it takes to receive radiation therapy and, thereby, reducing toxicity. The final goal is to improve tumor cure rates or to kill cancerous cells.
. North America dominates the global radiotherapy device market in terms of revenue due to growing number of cancer cases, rising technological advancements in radiotherapy equipment, also increasing focus of key vendors on expanding their presence in North America. Moreover, Asia-Pacific is anticipated to be the fastest growing region due to improvements in healthcare infrastructure, increasing aging population and rising number of cancer cases in this region.
Key market vendors for the global radiotherapy device market includeVarian Medical Systems, Inc. (U.S) Mitsubishi Electric Corporation (Japan), RaySearch Laboratories (Sweden), Mevion Medical Systems. Inc (U.S), Ion Beam Applications (IBA) (Belgium).These companies are using various strategies such as merger & acquisitions, collaboration, partnership and product launch to hold large market share.
You can read the complete article at":
http://www.occamsresearch.com/radiotherapy-market
